OR4A12P

Across TCGA pan-cancer cohorts, OR4A12P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR4A12P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR4A12P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4A12P expression acts as an unfavorable survival marker.

UCS, BLCA, and BRCA are the cancer types where OR4A12P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
BLCA	DFS	Tertile	All	0.078	0.594	<.001	63	view →
BRCA	OS	Tertile	II,III,IV	0.148	0.569	<.001	48	view →
LGG	DFS	Tertile	All	0.380	0.849	<.001	33	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	27	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
KIRC	DFS	Tertile	IV	0.143	0.648	.002	18	view →
THCA	DFS	Tertile	All	0.579	0.915	.028	18	view →
LUSC	DFS	Tertile	III,IV	0.124	0.632	.016	18	view →
STAD	DFS	Tertile	II,III,IV	0.467	0.647	.042	9	view →
UVM	OS	Tertile	All	0.315	0.711	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR4A12P–UCS (DFS)

Open the UCS breakdown →